Linking Epidemiology to Epigenomics—Where Are We Today?
Open Access
- 1 December 2010
- journal article
- Published by American Association for Cancer Research (AACR) in Cancer Prevention Research
- Vol. 3 (12) , 1505-1508
Abstract
Cancer is the consequence of genetic and epigenetic alterations. Genetic mutations likely result in part from exposure to environmental carcinogens, giving rise to a large field of cancer-prevention study of these carcinogens and ways to develop strategies to avoid them. Our understanding of regulatory epigenetic mechanisms associated with DNA methylation, histone modifications, and microRNA production is increasing rapidly. The involvement of these processes in carcinogenesis raises the possibility that environmental exposures may promote or prevent cancer through affecting the epigenome. Modifying the epigenome to prevent cancer is particularly intriguing because epigenetic alterations are potentially reversible, unlike gene mutations, and because certain dietary factors, such as the B-vitamin folate, may affect genes' DNA methylation status (as reported by Wallace et al., beginning on page 1552 in this issue of the journal). Rapidly improving techniques for assessing epigenetic alterations promise to yield important insights for cancer prevention. Cancer Prev Res; 3(12); 1505–8. ©2010 AACR.Keywords
All Related Versions
This publication has 36 references indexed in Scilit:
- Association between Folate Levels and CpG Island Hypermethylation in Normal Colorectal MucosaCancer Prevention Research, 2010
- Folate, cancer risk, and the Greek god, Proteus: a tale of two chameleonsNutrition Reviews, 2009
- Folic Acid and Risk of Prostate Cancer: Results From a Randomized Clinical TrialJNCI: Journal of the National Cancer Institute, 2009
- Folate and Cancer Prevention—Where to Next? CounterpointCancer Epidemiology, Biomarkers & Prevention, 2008
- Maternal nutrient supplementation counteracts bisphenol A-induced DNA hypomethylation in early developmentProceedings of the National Academy of Sciences, 2007
- Genetic polymorphisms in one-carbon metabolism: associations with CpG island methylator phenotype (CIMP) in colon cancer and the modifying effects of dietCarcinogenesis, 2007
- Folate: a magic bullet or a double edged sword for colorectal cancer prevention?Gut, 2006
- CpG island methylator phenotype underlies sporadic microsatellite instability and is tightly associated with BRAF mutation in colorectal cancerNature Genetics, 2006
- Effect of folic acid supplementation on genomic DNA methylation in patients with colorectal adenomaGut, 2005
- CpG island methylator phenotype in cancerNature Reviews Cancer, 2004